why choose us

First received: January 26, 2023

Clinical Trial: The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency

Study Type: INTERVENTIONAL


Official Title: The ENERGY Study: An Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Infant Subjects With Ectonucleotide Pyrophosphatase/ Phosphodieste

Brief Summary: The primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency.

Read more